NO20053312L - Benzofuranderivat. - Google Patents

Benzofuranderivat.

Info

Publication number
NO20053312L
NO20053312L NO20053312A NO20053312A NO20053312L NO 20053312 L NO20053312 L NO 20053312L NO 20053312 A NO20053312 A NO 20053312A NO 20053312 A NO20053312 A NO 20053312A NO 20053312 L NO20053312 L NO 20053312L
Authority
NO
Norway
Prior art keywords
optionally substituted
compound
alkyl
nitrogen
benzofuran derivative
Prior art date
Application number
NO20053312A
Other languages
English (en)
Norwegian (no)
Other versions
NO20053312D0 (no
Inventor
Masao Ohkuchi
Seiichi Sato
Tomoyuki Koshi
Natsuyo Kumai
Kyoko Yasuoka
Masahiro Tamura
Junko Totsuka
Toshimi Mizoguchi
Original Assignee
Kowa Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co filed Critical Kowa Co
Publication of NO20053312D0 publication Critical patent/NO20053312D0/no
Publication of NO20053312L publication Critical patent/NO20053312L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20053312A 2003-03-07 2005-07-06 Benzofuranderivat. NO20053312L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45256403P 2003-03-07 2003-03-07
PCT/JP2004/002633 WO2004078751A1 (ja) 2003-03-07 2004-03-03 ベンゾフラン誘導体

Publications (2)

Publication Number Publication Date
NO20053312D0 NO20053312D0 (no) 2005-07-06
NO20053312L true NO20053312L (no) 2005-10-04

Family

ID=32962732

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20053312A NO20053312L (no) 2003-03-07 2005-07-06 Benzofuranderivat.

Country Status (15)

Country Link
US (1) US7314877B2 (pt)
EP (1) EP1602655A4 (pt)
JP (1) JP4528722B2 (pt)
KR (1) KR20050105982A (pt)
CN (1) CN1326852C (pt)
AU (1) AU2004218161B9 (pt)
BR (1) BRPI0407519A (pt)
CA (1) CA2512280A1 (pt)
MX (1) MXPA05009500A (pt)
MY (1) MY137964A (pt)
NO (1) NO20053312L (pt)
NZ (1) NZ541064A (pt)
RU (1) RU2328495C2 (pt)
TW (1) TWI281397B (pt)
WO (1) WO2004078751A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0408359A (pt) 2003-03-18 2006-03-21 Kowa Co derivados de fenilpiridazina solúveis em água e medicamentos contendo os mesmos
EP1604988A1 (en) * 2004-05-18 2005-12-14 Sanofi-Aventis Deutschland GmbH Pyridazinone derivatives, methods for producing them and their use as pharmaceuticals
DE102005057924A1 (de) * 2005-12-05 2007-06-06 Merck Patent Gmbh Pyridazinonderivate
AU2007222135B2 (en) 2006-03-09 2012-02-02 Om Pharma Immunomodulatory compounds and treatment of diseases related to an overproduction of inflammatory cytokines
FR2941947B1 (fr) * 2009-02-12 2011-03-25 Sanofi Aventis Derives de 3-benzofuranyl-indol-2-one subtitues en 3, leur preparation et leur application en therapeutique
CN101845032B (zh) * 2010-06-03 2011-11-30 广东德鑫制药有限公司 一种酚类化合物及用途
CN103003270B (zh) 2010-07-22 2014-11-12 扶桑药品工业株式会社 苯并呋喃酮化合物以及含有该化合物的药物组合物
KR101882172B1 (ko) * 2011-01-14 2018-07-26 스페로 트리넴, 인코포레이티드 자이라제 및 토포이소머라제 ⅳ 억제제의 제조방법
CN103998123B (zh) 2011-10-31 2016-08-24 韩国电力公社 用在干燥二氧化碳的捕集方法中的含胺或其化合物的固体二氧化碳吸收剂及其制造方法
KR101652199B1 (ko) * 2015-06-03 2016-08-30 영남대학교 산학협력단 신규 벤조퓨란온 유도체 화합물, 이의 제조 방법 및 이를 유효성분으로 포함하는 염증성 장질환 예방 또는 치료용 조성물
KR20180006522A (ko) 2016-07-07 2018-01-18 삼성디스플레이 주식회사 액정 조성물 및 이를 포함하는 액정 표시 장치
CN108440468B (zh) * 2018-04-17 2022-09-23 南华大学 2-(苯并呋喃-5-基)苯酚及其作为抗癌药物的应用
WO2020097258A1 (en) * 2018-11-06 2020-05-14 Edgewise Therapeutics, Inc. Pyridazinone compounds and uses thereof
SMT202300355T1 (it) 2018-11-06 2024-01-10 Edgewise Therapeutics Inc Composti di piridazinone e loro usi
KR102885525B1 (ko) 2018-11-06 2025-11-13 엣지와이즈 테라퓨틱스, 인크. 피리다지논 화합물 및 이의 용도
EP4473968A3 (en) 2020-05-13 2025-03-26 Edgewise Therapeutics, Inc. Pyridazinone compounds and uses thereof

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9127430D0 (en) * 1991-12-27 1992-02-19 Scras Benzofuranylimidazole derivatives
JP3093507B2 (ja) 1993-02-15 2000-10-03 キヤノン株式会社 液晶性化合物、これを含む液晶組成物、それを有する液晶素子、それらを用いた表示方法および表示装置
PT889889E (pt) * 1996-03-29 2007-01-31 Duphar Int Res Composto de piperazina e piperidina
ATE230740T1 (de) 1996-04-12 2003-01-15 Sumitomo Pharma Piperidinylpyrimidine derivate
JP3337992B2 (ja) * 1997-11-04 2002-10-28 ファイザー製薬株式会社 ５−置換ピコリン酸化合物及びその製造方法
BR9813998A (pt) 1997-11-19 2000-09-26 Kowa Co Novos derivados de piridazina e produtos medicinais contendo os mesmos como ingredientes efetivos
TWI241295B (en) 1998-03-02 2005-10-11 Kowa Co Pyridazine derivative and medicine containing the same as effect component
JP2000247959A (ja) 1999-02-26 2000-09-12 Kowa Co ピリダジン−３−オン誘導体及びこれを含有する医薬
JP2000290261A (ja) * 1999-04-01 2000-10-17 Mitsui Chemicals Inc ジヒドロピリダジノン誘導体およびそれを有効成分として含有する腫瘍壊死因子産生抑制剤
JP2003510278A (ja) * 1999-09-30 2003-03-18 スミスクライン・ビーチャム・コーポレイション カスパーゼおよびアポプトシス
JP4502435B2 (ja) 1999-11-30 2010-07-14 興和創薬株式会社 ４，５，６，７−テトラヒドロチエノ〔２，３−ｃ〕ピリジン系化合物
JP4548882B2 (ja) 1999-11-30 2010-09-22 興和創薬株式会社 ４，５，６，７−テトラヒドロチエノ〔２，３−ｃ〕ピリジン化合物
JP4548884B2 (ja) 1999-12-03 2010-09-22 興和創薬株式会社 ４，５，６，７−テトラヒドロチエノ〔２，３−ｃ〕ピリジン誘導体
IL150841A0 (en) 2000-02-09 2003-02-12 Hokuriku Pharmaceutical 1h-imidazopyridine derivatives
EP1261595A1 (en) 2000-02-21 2002-12-04 AstraZeneca AB Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents
US20030134880A1 (en) 2000-02-24 2003-07-17 Gordon Bruton Novel cd23 inhibitors
CA2397661C (en) 2000-03-01 2012-01-03 Janssen Pharmaceutica N.V. 2,4-disubstituted thiazolyl derivatives
US6664256B1 (en) 2000-07-10 2003-12-16 Kowa Co., Ltd. Phenylpyridazine compounds and medicines containing the same
US6861428B2 (en) 2001-09-26 2005-03-01 Kowa Co., Ltd. Water-soluble phenylpyridazine compounds and compositions containing the same
US6869954B2 (en) 2001-09-26 2005-03-22 Kowa Co., Ltd. Water-soluble phenylpyridazine compounds and compositions containing the same
JP3774710B2 (ja) 2003-06-27 2006-05-17 横浜ゴム株式会社 空気入りタイヤ

Also Published As

Publication number Publication date
NO20053312D0 (no) 2005-07-06
US20060189621A1 (en) 2006-08-24
AU2004218161A1 (en) 2004-09-16
EP1602655A1 (en) 2005-12-07
MXPA05009500A (es) 2005-10-18
CN1326852C (zh) 2007-07-18
JP4528722B2 (ja) 2010-08-18
CA2512280A1 (en) 2004-09-16
CN1756753A (zh) 2006-04-05
TWI281397B (en) 2007-05-21
TW200420292A (en) 2004-10-16
WO2004078751A1 (ja) 2004-09-16
KR20050105982A (ko) 2005-11-08
AU2004218161B9 (en) 2009-11-26
EP1602655A4 (en) 2010-06-09
BRPI0407519A (pt) 2006-02-14
MY137964A (en) 2009-04-30
US7314877B2 (en) 2008-01-01
JPWO2004078751A1 (ja) 2006-06-08
HK1087105A1 (en) 2006-10-06
RU2328495C2 (ru) 2008-07-10
AU2004218161B2 (en) 2009-10-29
NZ541064A (en) 2007-09-28
RU2005131018A (ru) 2006-02-10

Similar Documents

Publication Publication Date Title
ATE324371T1 (de) N-substituierte heterocyclische nichtaryl- nmda/nr2b-antagonisten
CY1109441T1 (el) Ενδιαμεσα προϊοντα για την παραγωγη διοξανιου-2-αλκυλκαρβαμικου
NO20082561L (no) Nye koblede pyrrolderivater
TW200500339A (en) Pyrrolidine derivatives, and process for the preparation
NO20045486L (no) Nye forbindelser og deres anvendelse
MXPA02011370A (es) Iminoazinas substituidas.
MX2009006334A (es) Derivados de heteroaril-pirrolidinil- y -piperidinil-cetona.
DE602004009200D1 (de) Tetrahydrochinazolinderivate als cfr-antagonisten
TW200619215A (en) Asymmetric synthesis of dihydrobenzofuran derivatives
WO2006100082A3 (de) Substituierte oxindol-derivate, diese enthaltende arzneimittel und deren verwendung
TW200630374A (en) Thiazolyldihydroindazoles
TW200420292A (en) Benzofuran derivative
NO20052182L (no) Nye forbindelser
DE602004005881D1 (de) Substituierte pyrazinonverbindungen zur behandlung von entzündungen
TW200702330A (en) 3,4,5-Substituted piperidines
GEP20104964B (en) 3-aminocarbazole compounds, pharmaceutical composition containing the same and method for the preparation thereof
DE602004018811D1 (de) Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren
TW200744589A (en) Pharmaceutical composition
GEP20063896B (en) New heterocyclic oxime compound, method for production of the same and pharmaceutical composition comprising the same
ATE469887T1 (de) Substituierte heterocyclische verbindungen und deren verwendung zur behandlung multipler medikamentenresistenz
SI1845780T1 (sl) Uporaba derivatov metilfenidata
FR2894578B1 (fr) Derives heterocycliques, leur preparation et leur application en therapeutique.
TW200510312A (en) Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
DE602006013828D1 (en) 4-aryloxy-chinolin-derivate als 5-ht6-modulatoren
AR026673A1 (es) Benzoilpirazoles sustituidos por 3-(4,5-dihidroisoxazol-3-ilo)

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application